O
Olema Pharmaceuticals, Inc. (OLMA)
NMS – Real vaqt narxi. Valyuta: USD
13.97
-0.89 (-5.99%)
Yopilishda: May 12, 2026, 4:00 PM EDT
13.94
-0.03 (-0.21%)
Bozor oldidan: May 13, 2026, 4:13 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
13.97
-0.89 (-5.99%)
Yopilishda: May 12, 2026, 4:00 PM EDT
13.94
-0.03 (-0.21%)
Bozor oldidan: May 13, 2026, 4:13 AM EDT
| Tarkibi | |
|---|---|
| 1.80% | Insayderlar egalik qilgan aksiyalar ulushi |
| 103.31% | Institusional investorlar egalik qilgan aksiyalar ulushi |
| 105.20% | Institusional investorlar egalik qilgan erkin aksiyalar ulushi |
| 271 | Institusional investorlar soni |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8.51M | 2025-12-31 | 9.74% | $126.78M |
| Paradigm Biocapital Advisors LP | 7.54M | 2025-12-31 | 8.64% | $112.41M |
| Janus Henderson Group PLC | 6.71M | 2025-12-31 | 7.68% | $99.98M |
| Blackrock Inc. | 5.56M | 2025-12-31 | 6.37% | $82.89M |
| BVF Inc. | 5.30M | 2025-12-31 | 6.06% | $78.91M |
| FMR, LLC | 5.02M | 2025-12-31 | 5.75% | $74.84M |
| Vanguard Group Inc | 3.56M | 2025-12-31 | 4.08% | $53.06M |
| Siren, L.L.C. | 3.30M | 2025-12-31 | 3.78% | $49.18M |
| Logos Global Management LP | 3.21M | 2025-12-31 | 3.67% | $47.81M |
| Cormorant Asset Management, LP | 2.75M | 2025-12-31 | 3.15% | $40.97M |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.59M | 2026-03-31 | 2.96% | $38.54M |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.23M | 2025-12-31 | 2.56% | $33.26M |
| iShares Trust-iShares Russell 2000 ETF | 1.69M | 2026-03-31 | 1.93% | $25.13M |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.50M | 2026-03-31 | 1.72% | $22.35M |
| Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. | 1.11M | 2026-03-31 | 1.27% | $16.55M |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.00M | 2026-02-28 | 1.15% | $14.97M |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 893,200 | 2025-10-31 | 1.02% | $12.14M |
| T. Rowe Price Health Sciences Fund, Inc. | 825,139 | 2025-12-31 | 0.94% | $12.29M |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 777,200 | 2026-03-31 | 0.89% | $11.58M |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | 772,189 | 2025-10-31 | 0.89% | $10.50M |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 750,000 | 2026-03-31 | 0.86% | $11.17M |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 693,100 | 2026-03-31 | 0.79% | $10.33M |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 666,913 | 2025-12-31 | 0.76% | $9.94M |
| Columbia Funds Series Trust I-Columbia Small Cap Value Discovery Fund | 633,768 | 2025-10-31 | 0.92% | $15.43M |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 605,022 | 2025-11-30 | 0.88% | $14.39M |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 569,000 | 2025-12-31 | 0.83% | $13.77M |